[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
this is a test
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Ethical Consideration::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 8, Issue 4 (Winter 2014) ::
Iranian J Nutr Sci Food Technol 2014, 8(4): 40-49 Back to browse issues page
Effects of dietary resveratrol supplementation on liver enzymes, hs-CRP, and hepatic steatosis in patients with nonalcoholic fatty liver disease
F Faghihzadeh , P Adibi , A Hekmatdoost *
Abstract:   (16384 Views)
Background and Objective: Resveratrol is an antioxidant compound that has been shown to be effective in the management of some diseases. The present study investigated the effects of resveratrol supplementation on serum liver enzymes, inflammatory factors, and the degree of hepatic steatosis in patients with nonalcoholic fatty livers. Materials and Methods: Fifty patients with NAFLD were randomly assigned to groups that received either resveratrol or a placebo. All patients received 1 capsule (resveratrol or placebo) daily. Both groups were advised to follow an energy-balanced diet and to be physically active. Liver enzymes, inflammatory markers, hepatic steatosis, anthropometric measurements and physical activity were assessed at baseline and at the end of the study. The SPSS 16 and Kolmogorov-Smirnov, paired t-test, t-test and chi-2 were used for data analysis. Results: No significant differences were observed for the monitored variables between the two groups at baseline. After treatment, the group consuming dietary resveratrol supplementation showed a statistically significant decrease over the control group for ALT and hs-CRP (p < 0.05). Ultrasonography also showed a significant decrease in the level of steatosis in the resveratrol group over the placebo group (p < 0.05). Conclusion: The positive effects of resveratrol supplementation in improving liver enzyme values and the degree of hepatic steatosis in patients with nonalcoholic fatty liver disease suggest that it can be recommended for such patients. Keywords: NAFLD, Resveratrol, hs-CRP
Keywords: NAFLD, Resveratrol, hs-CRP
Full-Text [PDF 311 kb]   (6056 Downloads)    
Article type: Research | Subject: nutrition
Received: 2014/01/27 | Accepted: 2014/01/27 | Published: 2014/01/27
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Faghihzadeh F, Adibi P, Hekmatdoost A. Effects of dietary resveratrol supplementation on liver enzymes, hs-CRP, and hepatic steatosis in patients with nonalcoholic fatty liver disease. Iranian J Nutr Sci Food Technol 2014; 8 (4) :40-49
URL: http://nsft.sbmu.ac.ir/article-1-1495-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 8, Issue 4 (Winter 2014) Back to browse issues page
Iranian Journal of  Nutrition Sciences and Food  Technology
Persian site map - English site map - Created in 0.04 seconds with 37 queries by YEKTAWEB 4710